HUTCHMED (China) Ltd (HMDCF)
HMDCF is quoted over the counter, not listed on an exchange. HUTCHMED (China) Ltd files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | HMDCF, quoted over the counter |
| SEC CIK | 0001648257 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Hong Kong |
| Incorporated in | Cayman Islands |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Group ' s ability to continue as a going concern for a reasonable period of time." | 20-F 2026-03-05 |
| Cash and burn | $71.3M cash; operating cash flow -$16.2M a quarter. | Report 2025-12-31 |
| Shares outstanding | 174,465,524 (2025-12-31); 174,320,219 a year earlier; 172,955,068 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers Zhong Tian LLP, Shenzhen, China | PCAOB Form AP 2026-04-08 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $548.5M | $456.9M | -$64.7M | $71.3M | $118.1M | $548.5M | 20-F 2026-03-05 |
| FY 2024 2024-12-31 | $630.2M | $37.7M | $497K | $154.0M | $106.2M | $630.2M | 20-F 2026-03-05 |
| FY 2023 2023-12-31 | $838.0M | $100.8M | $219.3M | $283.6M | $110.5M | $838.0M | 20-F 2026-03-05 |
| FY 2022 2022-12-31 | $426.4M | -$360.8M | -$268.6M | $313.3M | $18.1M | $426.4M | 20-F 2023-02-28 |
| FY 2021 2021-12-31 | $356.1M | -$194.6M | -$204.2M | $377.5M | $26.9M | $356.1M | 20-F 2023-02-28 |
| FY 2020 2020-12-31 | $228.0M | -$125.7M | -$62.1M | $235.6M | $26.9M | $228.0M | 20-F 2023-02-28 |
| FY 2019 2019-12-31 | $204.9M | -$106.0M | -$80.9M | $121.2M | $26.8M | $204.9M | 20-F 2022-03-03 |
| FY 2018 2018-12-31 | $214.1M | -$74.8M | -$32.8M | $86.0M | $26.7M | $214.1M | 20-F 2021-03-04 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2021-06-24 |
| Latest annual report | 20-F | 2026-03-05 |
| Latest quarterly / interim | 6-K | 2026-11-16 |
Source: SEC EDGAR submissions feed, 612 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier